Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells

Journal of Pathology

Volumn 182, Issue 4, 1997, Pages 404-413

  May, Felicity E B ^a   Westley, Bruce R ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

anti oestrogen; breast cancer; carcinoma; hITF; human; mRNA; oestrogen; pNR 2 pS2; pS2; stomach mucosa

Indexed keywords

ANDROSTANOLONE; ANTIESTROGEN; DEXAMETHASONE; ESTRADIOL; ESTROGEN; GROWTH FACTOR; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PROGESTERONE; PROMEGESTONE; TAMOXIFEN; TREFOIL PEPTIDE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; BASE SEQUENCE; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SMALL CELL; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MUCINS; MUSCLE PROTEINS; NEUROPEPTIDES; PEPTIDES; POLYMERASE CHAIN REACTION; PROTEINS; RNA, MESSENGER; STOMACH NEOPLASMS; TAMOXIFEN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030872079     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199708)182:4<404::AID-PATH875>3.0.CO;2-0     Document Type: Article

References (31)

1. Poulsom R, Wright NA. Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. Am J Physiol 1993; 265: 205-213.
2. Carr MD, Bauer CJ, Gradwell MJ, Feeney J. Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein. Proc Natl Acad Sci USA 1994; 91: 1084-1088.
3. 13C NMR resonance assignments and secondary structure determination of the pNR-2/pS2 single domain trefoil peptide. Eur J Biochem 1995; 233: 847-855.
4. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982; 10: 7895-7903.
5. May FEB, Westley BR. Cloning of estrogen regulated mRNA sequences from human breast cancer cells. Cancer Res 1986; 46: 6034-6038.
6. Tomasetto C, Rio MC, Gautier C. et al. hSP, the domain-duplicated homolog of the pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 1990; 9: 407-414.
7. Podolsky DK, Lynch-Devaney K, Stow JL, et al. Identification of human intestinal trefoil factor: goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993; 268: 6694-6702.
8. Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci USA 1991; 88: 11017-11021.
9. Hauser F, Poulsom R, Chinery R, et al. hPl.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci USA 1993; 90: 6961-6965.
10. Wright NA, Poulsom R, Stamp GW, et al. Epidermal growth factor (EGF/LRO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990; 162: 279-284.
11. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky K. Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway. J Clin Invest 1994; 94: 376-383.
12. Chinery R, Cox HM. Modulation of epidermal growth factor effects on epithelial ion transport by intestinal trefoil factor. Br J Pharmacol 1995; 115: 77-80.
13. Playford RJ, Marchbank T, Goodlad RA, et al. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci USA 1996; 93: 2137-2142.
14. Williams R, Stamp GHW, Gilbert C, Pignatelli M, Lalani E-N. pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel. J Cell Sci 1996; 109: 63-71.
15. Henry JA, Nicholson S, Hennessy C, Lennard TWJ, May FEB, Westley BR. Expression of the estrogen-regulated pNR-2 mRNA in human breast cancer: relation to estrogen receptor mRNA levels and response to tamoxifen therapy. Br J Cancer 1989; 61: 32-38.
16. Wilson YG, Rhodes M, Ibrahim NBN, Padfield CJH, Cawthorn SJ. Immunocytochemical staining of pS2 protein in fine-needle aspirate from breast cancer is an accurate guide to response to tamoxifen in patients aged over 70 years. Br J Surg 1994; 81: 1155-1158.
17. Schwanz LH, Koerner FC, Edgerton SM, et al. pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Cancer Res 1991; 51: 624-628.
18. Theisinger B, Welter C, Seitz G, et al. Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur J Cancer 1991; 27: 770-773.
19. Welter C, Theisinger B, Seitz G, et al. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab Invent 1992; 66: 187-192.
20. May FEB, Westley BR. Identification and characterization of estrogen-regulated RNAs in human breast cancer cells. J Biol Chem 1988; 263: 12901-12908.
21. Westley BR, Hölzel F, May FEB. Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line. J Steroid Biochem 1989; 32: 363-372.
22. Healicon RM, Westley BR, May FEB. Isolation and characterization of an oestrogen-responsive breast cancer cell line, EFF-3. Int J Cancer 1993; 53: 388-394.
23. Piggott NH, Henry JA, May FEB, Westley BR. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J Pathol 1991; 163: 95-104.
24. Chinery R, Bates PA, De A, Freemont PS. Characterisation of the single-copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers. FEBS Lett 1995; 357: 50-54.
25. Henry JA, Bennett MK, Piggott NH, Levett D, May FEB, Westley BR. Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br J Cancer 1991; 64: 677-682.
26. Theisinger B, Seitz G, Dooley S, Welter C. A second trefoil protein. ITF/hP1.B, is transcribed in human breast cancer. Breast Cancer Res Treatment 1996; 38: 145-151.
27. Foekens JA, Van Putten WLJ, Portengen H, et al. Prognostic value of pS2 and cathepsin D in 710 human primary breast tumours: multivariate analysis. J Clin Oncol 1993; 11: 899-908.
28. Henry JA, Piggott NH, Mallick UK, Nicholson S, Farndon JR, Westley BR. pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br J Cancer 1991; 63: 615-622.
29. Berry M, Nunez A-M, Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 1989; 86: 1218-1222.
30. May FEB, Westley BR. Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen-related RNAs in human breast cancer cells. J Biol Chem 1987; 262: 15894-15899.
31. Johnson MD, Westley BR, May FEB. Oestrogen activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells. Br J Cancer 1989; 59: 727-738.